Zylla, Maura M.
Brachmann, Johannes
Lewalter, Thorsten
Kuck, Karl-Heinz
Andresen, Dietrich
Willems, Stephan
Spitzer, Stefan G.
Straube, Florian
Schumacher, Burghard
Eckardt, Lars
Hochadel, Matthias
Senges, Jochen
Katus, Hugo A.
Thomas, Dierk
Funding for this research was provided by:
Stiftung Institut fuer Herzinfarktforschung
Medtronic
Biosense Webster
Biotronik
Article History
Received: 23 July 2019
Accepted: 15 November 2019
First Online: 29 November 2019
Compliance with ethical standards
:
: D.T. reports receiving lecture fees/honoraria from Bayer Vital, Boehringer Ingelheim Pharma, Bristol-Myers Squibb, Daiichi Sankyo, Medtronic, Pfizer Pharma, Sanofi-Aventis, St. Jude Medical and ZOLL CMS. T.L. reports receiving modest honoraria for lectures by Medtronic, Biotronik, Abbott, Boston Scientific. S.G.S. reports receiving lecture fees from, Medtronic, BMS, Edwards, Pfizer and Sanofi-Aventis, as well as lecture honoraria and travel support from Abbott within the last 24 months. F.S. reports honoraria for lectures from Bristol-Myers Squibb, Daichii Sankyo, I-Med-Pro, Korese, Medtronic, wikonet GmbH, educational and travel support by Pfizer, as well as advisory board activities for Boehringer Ingelheim (last 24 months and outside the submitted work). L.E. reports consultant fees, speaking honoraria, and travel expenses from Abbott, Bayer, Biosense Webster, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Daiichi Sankyo, Medtronic, Pfizer, and Sanofi-Aventis. L.E.’s research has been supported by the German Research Foundation (DFG) and German Heart Foundation outside the submitted work. J.S. and M.H. state that the long-term follow-up and a prior publications were partially supported by unrestricted grants from Medtronic, Biosense Webster and Biotronik.